These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11191283)

  • 1. The acid sphingomyelinase inhibitor SR33557 counteracts TNF-alpha-mediated potentiation of IL-1beta-induced NF-kappaB activation in the insulin-producing cell line Rinm5F.
    Saldeen J; Jaffrézou JP; Welsh N
    Autoimmunity; 2000 Dec; 32(4):241-54. PubMed ID: 11191283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
    Katsuyama K; Shichiri M; Marumo F; Hirata Y
    Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation.
    Higuchi M; Singh S; Jaffrezou JP; Aggarwal BB
    J Immunol; 1996 Jul; 157(1):297-304. PubMed ID: 8683130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes.
    Pahan K; Sheikh FG; Khan M; Namboodiri AM; Singh I
    J Biol Chem; 1998 Jan; 273(5):2591-600. PubMed ID: 9446561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells.
    Azevedo-Martins AK; Lortz S; Lenzen S; Curi R; Eizirik DL; Tiedge M
    Diabetes; 2003 Jan; 52(1):93-101. PubMed ID: 12502498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB.
    Marcus JS; Karackattu SL; Fleegal MA; Sumners C
    Glia; 2003 Jan; 41(2):152-60. PubMed ID: 12509805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
    Darville MI; Eizirik DL
    Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes.
    Zeng C; Lee JT; Chen H; Chen S; Hsu CY; Xu J
    J Neurochem; 2005 Aug; 94(3):703-12. PubMed ID: 16033420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells.
    Chen CC; Sun YT; Chen JJ; Chang YJ
    Mol Pharmacol; 2001 Mar; 59(3):493-500. PubMed ID: 11179444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
    Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid sphingomyelinase-derived ceramide is not required for inflammatory cytokine signalling in murine macrophages.
    Manthey CL; Schuchman EH
    Cytokine; 1998 Sep; 10(9):654-61. PubMed ID: 9770326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
    Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
    Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
    Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
    Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K; Hirata Y
    J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 MAPK inhibits JNK2 and mediates cytokine-activated iNOS induction and apoptosis independently of NF-KB translocation in insulin-producing cells.
    Saldeen J; Welsh N
    Eur Cytokine Netw; 2004; 15(1):47-52. PubMed ID: 15217752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells.
    Sawada M; Nakashima S; Kiyono T; Yamada J; Hara S; Nakagawa M; Shinoda J; Sakai N
    Exp Cell Res; 2002 Feb; 273(2):157-68. PubMed ID: 11822871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F.
    Welsh N
    J Biol Chem; 1996 Apr; 271(14):8307-12. PubMed ID: 8626526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of inducible nitric oxide synthase in proinflammatory cytokine-stimulated human primary astrocytes.
    Jana M; Anderson JA; Saha RN; Liu X; Pahan K
    Free Radic Biol Med; 2005 Mar; 38(5):655-64. PubMed ID: 15683721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
    Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
    J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis.
    Baker MS; Chen X; Cao XC; Kaufman DB
    J Surg Res; 2001 May; 97(2):117-22. PubMed ID: 11341786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.